This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Japan Tobacco Inc.. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2008)
- Takatsuki, JP (2014)
Company Filing History:
Years Active: 2008-2014
Title: Masahiro Tamaru: Innovator in Antitumor Compounds
Introduction
Masahiro Tamaru is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target undesirable cell proliferation. His work is crucial in the ongoing fight against cancer and other related diseases.
Latest Patents
Masahiro Tamaru holds 2 patents, with his latest invention focusing on a pyrimidine compound and its medical applications. This invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof, which is designed to therapeutically or prophylactically treat undesirable cell proliferation. The compound demonstrates superior activity in suppressing such proliferation, particularly showcasing antitumor activity. It is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and similar conditions. Furthermore, the compound can be more effective when used in combination with other antitumor agents, such as alkylating agents or metabolism antagonists.
Career Highlights
Masahiro Tamaru is associated with Japan Tobacco Inc., where he continues to innovate and contribute to the field of medicinal chemistry. His work has garnered attention for its potential impact on cancer treatment and patient care.
Collaborations
He has collaborated with notable colleagues, including Hisashi Kawasaki and Hiroyuki Abe, to advance research and development in his field.
Conclusion
Masahiro Tamaru's contributions to the development of antitumor compounds highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
